Does Pharmacy Software Typically Include Tigecycline Dosing Guidelines?
Most clinical pharmacy software and drug databases—like Lexicomp, Micromedex, or Epic's drug modules—include tigecycline dosing guidelines. Tigecycline (Tygacil), an IV glycylcycline antibiotic, has standard adult doses of 100 mg loading, then 50 mg IV every 12 hours for complicated skin/skin structure infections or intra-abdominal infections. Adjust for renal impairment (no change needed) or hepatic issues (50 mg every 12 hours maintenance). Pediatric dosing starts at 1.2 mg/kg loading.[1][2]
Which Specific Pharmacy Systems Support This?
- Cerner and Epic: Built-in order sets and alerts pull FDA-approved tigecycline dosing, including obesity adjustments (e.g., 100 mg load, 75-100 mg q12h for BMI >30).
- Medi-Span or First Databank: Integrated into chains like Walgreens or CVS systems for retail verification, covering interactions with warfarin or oral contraceptives.
- Wolters Kluwer (UpToDate/Lexicomp): Real-time guidelines with evidence ratings; accessible via apps for hospital pharmacists.
Check your system's drug monograph search for 'tigecycline' or 'Tygacil' to confirm.
How Accurate Are These Guidelines?
They align with FDA labeling and IDSA guidelines but may lag on emerging resistance data (e.g., tigecycline's limited efficacy against Pseudomonas). Software flags overdose risks, like C. difficile warnings, but pharmacists verify manually for off-label uses like ventilator-associated pneumonia.[3]
Tigecycline Patent and Generic Availability
Tygacil's key patents expired in 2023 in the US, with generics from Hikma and others approved by FDA in 2024. Pharmacy software now lists AB-rated equivalents, potentially lowering costs from $200+ per dose to under $50.[4]
Common Dosing Errors Pharmacists Catch
Software alerts prevent issues like skipping the loading dose (critical for efficacy) or using in pregnancy (Category D). In obesity, fixed dosing underperforms, so tools suggest weight-based tweaks.[1]
[1]: FDA Tygacil Prescribing Information - https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/021821s021lbl.pdf
[2]: Lexicomp Tigecycline Monograph - https://online.lexi.com
[3]: IDSA Skin and Soft Tissue Infections Guidelines - https://www.idsociety.org/practice-guideline/skin-and-soft-tissue-infections/
[4]: DrugPatentWatch.com Tygacil Patents - https://www.drugpatentwatch.com/p/tradename/TYGACIL